CamScanner Releases 2025 Annual Summary Highlighting Breakthrough Innovation and a Global User Base Exceeding 300 Million
NEW YORK, Dec. 18, 2025 /PRNewswire/ — CamScanner today released its 2025 Annual Summary, marking a year of accelerated product innovation, strengthened AI... Read more.
For A Bright Future Foundation Names Jennifer Sky Carlos as 2025 Creative Arts Scholarship Recipient
The Foundation honors an outstanding scholar committed to inspiring her community through music MIAMI, Dec. 18, 2025 /PRNewswire/ — Louis Hernandez Jr.’s... Read more.
Armada Agreement with United States Department of Energy to Accelerate Genesis Mission
SAN FRANCISCO, Dec. 18, 2025 /PRNewswire/ — Armada today announced it has entered into a Memorandum of Understanding (MOU) to become an official collaborator... Read more.
Boatsetter and Getmyboat Announce Merger, Forming a Powerhouse Marketplace for Boat Rentals & On-the-Water Adventure
As demand for boating and outdoor recreation accelerates, the two companies unite to expand global access and pioneer the next era of industry growth. MIAMI, Dec.... Read more.
Stony Brook University Develops Machine Learning Models that Predict PV System Underperformance on Heterogeneous Portfolios
STONY BROOK, N.Y., Dec. 18, 2025 /PRNewswire/ — Researchers Yue Zhao and Kang Pu from Stony Brook University—in collaboration with Ecosuite’s John... Read more.
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies
Niowave will expand its agreement to supply Actinium-225, a highly promising medical isotope, to AstraZeneca 10-year supply agreement will help advance new radioconjugate... Read more.
Universal Music Group and Splice to Collaborate on the Next Generation of AI-powered Music Creation Tools for Artists
SANTA MONICA, Calif., Dec. 18, 2025 /PRNewswire/ — Universal Music Group (UMG), the world leader in music-based entertainment, and Splice, the world’s... Read more.
Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer
Phase 1 trial in aggressive brain cancer (Glioblastoma) is the first clinical trial of uTREAT® belonging to Curasight’s treatment platform No patient safety... Read more.
Achieve closes its first debt settlement fee securitization
$217.2 million in rated notes backed by fees earned through Achieve Debt Relief SAN MATEO, Calif., Dec. 18, 2025 /PRNewswire/ — Achieve, the leader in digital... Read more.
Ripple Effect Communications Celebrates 25th Anniversary and Visionary B2B PR Model
Next Gen PR Agency Promotes New AI-Driven Approach to Ensure B2B Brands Remain Visible and Credible in the Age of Artificial Intelligence (AI). BOSTON, Dec. 18,... Read more.